Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › RVMD
SUPERSTRING CAPITAL MANAGEMENT LP position in RVMD
REVOLUTION MEDICINES INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 51,053 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$9.6M, representing 6.04% of its reported portfolio and ranking #6 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed RVMD holdings in 2 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's RVMD position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in RVMD in Q4 2025 at 54,879 shares (US$4.4M). The position peaked in Q2 2026 at 51,053 shares, worth US$9.6M. Across 2 filings, SUPERSTRING CAPITAL MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 51,053 shares valued at US$9.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 54.88K | $4.37M | New |
| Q2 2026 | 51.05K | $9.56M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.95M sh · $551.84M · Q2 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held RVMD?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed RVMD holdings in 2 of the last 3 reported quarters, going back to Q4 2025.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in RVMD?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 51.05K shares of RVMD (REVOLUTION MEDICINES INC), valued at $9.56M, representing 6.04% of its reported portfolio and ranking #6.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling RVMD?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in RVMD. The position peaked in Q2 2026 at 51.05K shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.